Health In Tech: A $156 Million Pipeline Repriced to 3% to 7%
A three-week-old CEO, a guidance line that now assumes almost nothing converts, and an A-rated carrier promise now on its third consecutive call
HIT · Earnings Call · 2026-11-12
The pipeline didn't shrink — the belief in it did
Health In Tech put a big number in front of investors on Thursday: $156.4 million of pipeline revenue as of October 30, policies "in quoting or binding stage," roughly 70% of it tied to January 1, 2027 effective dates. On the August call, an almost identical pipeline was framed as a marketing asset. This time it arrived with a haircut attached, and the haircut is the story.
the remaining $153.8 million carries an expected conversion rate of 3% to 7%, meaning it would generate $9.3 million to $10.7 million revenue just for these 3 months policies.
Three months ago, CFO Julia Qian described the company's own historical conversion rate as "about 15% to 40%" “our conversion rate is the range of about 15% to 40%.” — Julia Qian, Chief Financial Officer · 2026-08-13. The company has now re-underwritten its own funnel at roughly a quarter to a fifth of the low end of that range. Read plainly: the same $154 million of quoted opportunity that was worth $23 million-to-$61 million in August's math is worth $9 million-to-$11 million in November's. Nothing about the pipeline changed. The credibility of the pipeline did.
And note what the new full-year outlook of "approximately $30 million" actually is. Contracted revenue for the first nine months totaled $32.7 million; $24.4 million was already recognized, with $6.1 million scheduled into Q4. $24.4 million plus $6.1 million is $30.5 million. The 2026 guidance number is, to the decimal, the revenue already under contract. Management is implicitly crediting zero conversion from the $153.8 million of live quoting activity for the rest of the year — a silent admission that the funnel is not to be trusted until it binds.
The $45 million that became $30 million, and the CEO who won't repeat it
In August, an analyst walked through the bridges to a $45 million year. The new guide is a third lower. The proximate cause management offers is the carrier transition — an onboarding of a new carrier that forced manual workarounds and slowed intake — plus plan administration vendor fees now sitting in cost of revenue that dragged gross margin to 46.5% from 60.6%. Those are real mechanics, but they are the same mechanics that were described as "substantially behind us" a quarter ago.
What is genuinely new is the tone. Sanjay Shrestha, three weeks into the job, opened by disowning the numbers rather than explaining them: “we are not satisfied with our current revenue performance. Investment is necessary, but investment alone does not create value for all stakeholders.” — Sanjay K. Shrestha, Chief Executive Officer · 2026-11-12 His three priorities are commercial execution on the base business, commercializing the new products, and cost discipline — and both of those first two phrases are brand new to this company's keyword profile this quarter, arriving at the very top of the list while the old "pipeline revenue" framing slides down the page. That is a language regime change, not a product one.
The product calendar, meanwhile, keeps sliding right. The HitRix large-group marketplace that was slated to launch "in the next 2, 3 weeks" back in August now targets a minimum viable product in Q1 2027, with commercial contribution "Q2 at the earliest." HITChain is second-half 2027. The three-year rate stabilization program — which in May was "anticipating at least one in the second quarter" “we are anticipating at least one in the second quarter” — Tim Johnson, Chief Executive Officer · 2026-05-14 — has one signed client on the insurance side and a capital-markets leg still unresolved, with management openly acknowledging a holiday-season slip.
The recurring promise
The most instructive thing in the transcript is what Sanjay would not say. Asked about the A-rated carrier backstop for HitRix: “the last thing I want to do on my first earnings call as the CEO of the company is give you a timeline and not meet that.” — Sanjay K. Shrestha, Chief Executive Officer · 2026-11-12 That is a deliberate break from his predecessor's habit. In August, Tim Johnson said of the A-carrier: “we hope to have that done in the next -- I don't know, in the next 30 days, probably at the far end” — Tim Johnson, Chief Executive Officer · 2026-08-13, adding that securing it would “bump our projections at least, I don't know, 20% to 30% higher” — Tim Johnson, Chief Executive Officer · 2026-08-13. That was roughly ninety days ago. The rating is still not in hand, and the new carrier thesis that was supposed to unlock the alpha-house brokers is now described as a top-three priority with no date. The new CEO is, in effect, cleaning up a guidance practice.
The balance sheet is the actual business now
The quarter's ugliest line was a $5.3 million credit-loss provision, more than half of a $8.5 million receivables base, taken against a legacy surplus-admin receivable, aged carrier-transition receivables, and a pre-IPO loan receivable to a UK agency the company has decided not to pursue. The reconciliation in Q&A drifted between $5.3 million, $2.5 million and $3.5 million across two answers — an analyst pressed exactly that point and did not get a crisp answer. For a $28.7 million market cap, a write-off of this size is not housekeeping.
Net income went to -$3.1 million on the quarter and -$11.2 million for nine months, with adjusted EBITDA of -$3.9 million against positive $1.0 million a year ago. Operating margin sits near -41%. Free cash flow is running at roughly -$4 million a quarter, though the trajectory of operating cash burn — -$3.3M, -$2.9M, -$1.0M across Q1 to Q3 — is one of the few genuinely improving lines in the deck. Cash ended at $10.1 million versus $7.7 million entering the year, but that is a capital-markets outcome, not an operating one: cash is now worth more than a third of the entire equity.
Gross margin has compressed from a 79.9% peak to the high-40s, and management guides 45% to 50% — a structural reset, not a blip. Meanwhile effective SG&A is up 80% over two years while revenue declines. That is the opposite of the operating-leverage story this company sold in 2025.
What the tape already knows
The stock is down 92% from its December 2024 inception-era pricing, and 62.7% in the last ninety trading days alone, including a 55% slide over six weeks into this print; it sits 66% below its August 5 peak of $1.16. This is not a market that was surprised by a soft quarter — it is a market that has stopped paying for narrative. The only thing that re-rates a $29 million software company with $10 million of cash and a $154 million quoting funnel is a conversion number that stops being a footnote. The new CEO has bought himself one quarter to produce one. Whether he gets a second depends on whether the A-rated carrier, the first three-year bond placement, or the January 1 renewal season binds before the cash does.